CLINICAL_TRIALS
trial_result
· 2022-06-21
Clinical Trial Update: A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma [Phase 2]
Summary
Phase 2 trial update for men with metastatic prostatic adenocarcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rampart Health, L.L.C. | Conditions: Metastatic Prostatic Adenocarcinoma | Phase 2 | Status: COMPLETED